Summary
Elevance Health, Inc. (then operating as WellPoint, Inc.) issued this 8-K filing on January 12, 2009, to provide preliminary financial information ahead of its fourth-quarter 2008 earnings release. The company disclosed an estimated $349 million in net realized investment losses after taxes for the fourth quarter, primarily driven by losses in both equity securities ($212 million) and fixed maturity securities ($137 million). Despite these investment losses, WellPoint reassured investors about its strong capital position, estimating that its aggregate statutory capital levels as of December 31, 2008, would significantly exceed Blue Cross and Blue Shield Association and state regulatory requirements by approximately $1.6 billion and $4.6 billion, respectively. The company explicitly stated it was in a quiet period and would not discuss earnings projections at the investor conference where this information was presented.
Key Highlights
- 1Preliminary disclosure of estimated Q4 2008 net realized investment losses totaling $349 million after taxes.
- 2Investment losses comprised $212 million from equity securities and $137 million from fixed maturity securities.
- 3Estimated aggregate statutory capital levels as of December 31, 2008, to exceed Blue Cross and Blue Shield Association requirements by approximately $1.6 billion.
- 4Estimated aggregate statutory capital levels as of December 31, 2008, to exceed state regulatory levels by approximately $4.6 billion.
- 5The company was in a quiet period and would not discuss earnings projections at the investor conference.
- 6The filing serves as a Regulation FD disclosure, providing material non-public information to all investors simultaneously.
- 7The company included a comprehensive safe harbor statement regarding forward-looking statements and associated risks.